Search Results - "Stucky, Ashley"

Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection During Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study) by Arashiro, Takeshi, Arima, Yuzo, Muraoka, Hirokazu, Sato, Akihiro, Oba, Kunihiro, Uehara, Yuki, Arioka, Hiroko, Yanai, Hideki, Kuramochi, Jin, Ihara, Genei, Chubachi, Kumi, Yanagisawa, Naoki, Nagura, Yoshito, Kato, Yasuyuki, Ueda, Akihiro, Numata, Akira, Kato, Hideaki, Ishii, Koji, Ooki, Takao, Oka, Hideaki, Nishida, Yusuke, Stucky, Ashley, Smith, Chris, Hibberd, Martin, Ariyoshi, Koya, Suzuki, Motoi

“…Abstract Background Although several coronavirus disease 2019 (COVID-19) vaccines initially showed high efficacy, there have been concerns because of waning…”
Get full text

Social and Behavioral Factors Associated with Lack of Intent to Receive COVID-19 Vaccine, Japan by Arashiro, Takeshi, Arima, Yuzo, Stucky, Ashley, Smith, Chris, Hibberd, Martin, Ariyoshi, Koya, Suzuki, Motoi

“…Persons in Japan who did not intend to receive COVID-19 vaccines after widespread rollout were less likely than others to engage in preventive measures or to…”
Get full text

Immune escape and waning immunity of COVID-19 monovalent mRNA vaccines against symptomatic infection with BA.1/BA.2 and BA.5 in Japan by Arashiro, Takeshi, Arima, Yuzo, Kuramochi, Jin, Muraoka, Hirokazu, Sato, Akihiro, Chubachi, Kumi, Oba, Kunihiro, Yanai, Atsushi, Arioka, Hiroko, Uehara, Yuki, Ihara, Genei, Kato, Yasuyuki, Yanagisawa, Naoki, Nagura, Yoshito, Yanai, Hideki, Ueda, Akihiro, Numata, Akira, Kato, Hideaki, Oka, Hideaki, Nishida, Yusuke, Ishii, Koji, Ooki, Takao, Nidaira, Yuki, Asami, Takahiro, Jinta, Torahiko, Nakamura, Akira, Taniyama, Daisuke, Yamamoto, Kei, Tanaka, Katsushi, Ueshima, Kankuro, Fuwa, Tetsuji, Stucky, Ashley, Suzuki, Tadaki, Smith, Chris, Hibberd, Martin, Ariyoshi, Koya, Suzuki, Motoi

“…•Immune escape variants and waning immunity are major concerns for COVID-19.•Booster doses initially provided similarly high protection against BA.5 and…”
Get full text

COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection during Delta-dominant and Omicron-dominant periods in Japan: a multi-center prospective case-control study (FASCINATE study) by Arashiro, Takeshi, Arima, Yuzo, Muraoka, Hirokazu, Sato, Akihiro, Oba, Kunihiro, Uehara, Yuki, Arioka, Hiroko, Yanai, Hideki, Kuramochi, Jin, Ihara, Genei, Chubachi, Kumi, Yanagisawa, Naoki, Nagura, Yoshito, Kato, Yasuyuki, Ueda, Akihiro, Numata, Akira, Kato, Hideaki, Ishii, Koji, Ooki, Takao, Oka, Hideaki, Nishida, Yusuke, Stucky, Ashley, Smith, Chris, Hibberd, Martin, Ariyoshi, Koya, Suzuki, Motoi

Get full text

COVID-19 vaccine effectiveness against severe COVID-19 requiring oxygen therapy, invasive mechanical ventilation, and death in Japan: A multicenter case-control study (MOTIVATE study) by Arashiro, Takeshi, Miwa, Maki, Nakagawa, Hidenori, Takamatsu, Junpei, Oba, Kunihiro, Fujimi, Satoshi, Kikuchi, Hitoshi, Iwasawa, Takamasa, Kanbe, Fumiko, Oyama, Keisuke, Kanai, Masayuki, Ogata, Yoshitaka, Asakura, Takanori, Asami, Takahiro, Mizuno, Keiko, Sugita, Manabu, Jinta, Torahiko, Nishida, Yusuke, Kato, Hideaki, Atagi, Kazuaki, Higaki, Taiki, Nakano, Yoshio, Tsutsumi, Takeya, Doi, Kent, Okugawa, Shu, Ueda, Akihiro, Nakamura, Akira, Yoshida, Toru, Shimada-Sammori, Kaoru, Shimizu, Keiki, Fujita, Yasuo, Okochi, Yasumi, Tochitani, Kentaro, Nakanishi, Asuka, Rinka, Hiroshi, Taniyama, Daisuke, Yamaguchi, Asase, Uchikura, Toshio, Matsunaga, Maiko, Aono, Hiromi, Hamaguchi, Masanari, Motoda, Kentaro, Nakayama, Sohei, Yamamoto, Kei, Oka, Hideaki, Tanaka, Katsushi, Inoue, Takeshi, Kobayashi, Mieko, Fujitani, Shigeki, Tsukahara, Maki, Takeda, Saki, Stucky, Ashley, Suzuki, Tadaki, Smith, Chris, Hibberd, Martin, Ariyoshi, Koya, Fujino, Yuji, Arima, Yuzo, Takeda, Shinhiro, Hashimoto, Satoru, Suzuki, Motoi

“…•Assessing vaccine effectiveness (VE) became challenging due to incidental infection.•A case-control study in 24 hospitals during Delta and Omicron with…”
Get full text

Letter to the editor: Importance of considering high-risk behaviours in COVID-19 vaccine effectiveness estimates with observational studies by Arashiro, Takeshi, Arima, Yuzo, Kuramochi, Jin, Muraoka, Hirokazu, Sato, Akihiro, Chubachi, Kumi, Oba, Kunihiro, Yanai, Atsushi, Arioka, Hiroko, Uehara, Yuki, Ihara, Genei, Kato, Yasuyuki, Yanagisawa, Naoki, Nagura, Yoshito, Yanai, Hideki, Ueda, Akihiro, Numata, Akira, Kato, Hideaki, Oka, Hideaki, Nishida, Yusuke, Ooki, Takao, Nidaira, Yuki, Stucky, Ashley, Suzuki, Tadaki, Smith, Chris, Hibberd, Martin, Ariyoshi, Koya, Suzuki, Motoi

Get full text

Behavioral factors associated with SARS‐CoV‐2 infection in Japan by Arashiro, Takeshi, Arima, Yuzo, Muraoka, Hirokazu, Sato, Akihiro, Oba, Kunihiro, Uehara, Yuki, Arioka, Hiroko, Yanai, Hideki, Yanagisawa, Naoki, Nagura, Yoshito, Kato, Yasuyuki, Kato, Hideaki, Ueda, Akihiro, Ishii, Koji, Ooki, Takao, Oka, Hideaki, Nishida, Yusuke, Stucky, Ashley, Miyahara, Reiko, Smith, Chris, Hibberd, Martin, Ariyoshi, Koya, Suzuki, Motoi

“…Background The relative burden of COVID‐19 has been less severe in Japan. One reason for this may be the uniquely strict restrictions imposed upon…”
Get full text

Effectiveness of BA.1- and BA.4/BA. 5-Containing Bivalent COVID-19 mRNA Vaccines Against Symptomatic SARS-CoV-2 Infection During the BA.5-Dominant Period in Japan by Arashiro, Takeshi, Arima, Yuzo, Kuramochi, Jin, Muraoka, Hirokazu, Sato, Akihiro, Chubachi, Kumi, Yanai, Atsushi, Arioka, Hiroko, Uehara, Yuki, Ihara, Genei, Kato, Yasuyuki, Yanagisawa, Naoki, Ueda, Akihiro, Kato, Hideaki, Oka, Hideaki, Nishida, Yusuke, Nidaira, Yuki, Asami, Takahiro, Jinta, Torahiko, Nakamura, Akira, Oba, Kunihiro, Taniyama, Daisuke, Yamamoto, Kei, Tanaka, Katsushi, Ueshima, Kankuro, Fuwa, Tetsuji, Stucky, Ashley, Suzuki, Tadaki, Smith, Chris, Hibberd, Martin, Ariyoshi, Koya, Suzuki, Motoi

“…Abstract In this multicenter, prospective, test-negative, case-control study in Japan, the effectiveness of both BA.1-containing and BA.4/BA.5-containing…”
Get full text

Effectiveness of BA.1- and BA.4/BA.5-containing bivalent COVID-19 mRNA vaccines against symptomatic SARS-CoV-2 infection during the BA.5-dominant period in Japan by Arashiro, Takeshi, Arima, Yuzo, Kuramochi, Jin, Muraoka, Hirokazu, Sato, Akihiro, Chubachi, Kumi, Yanai, Atsushi, Arioka, Hiroko, Uehara, Yuki, Ihara, Genei, Kato, Yasuyuki, Yanagisawa, Naoki, Ueda, Akihiro, Kato, Hideaki, Oka, Hideaki, Nishida, Yusuke, Nidaira, Yuki, Asami, Takahiro, Jinta, Torahiko, Nakamura, Akira, Oba, Kunihiro, Taniyama, Daisuke, Yamamoto, Kei, Tanaka, Katsushi, Ueshima, Kankuro, Fuwa, Tetsuji, Stucky, Ashley, Suzuki, Tadaki, Smith, Chris, Hibberd, Martin, Ariyoshi, Koya, Suzuki, Motoi

“…In this multi-center prospective test-negative case-control study in Japan, the effectiveness of both BA.1-containing and BA.4/BA.5-containing bivalent…”
Get full text